ProfileGDS4718 / 208390_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 70% 70% 69% 73% 72% 66% 67% 72% 68% 73% 69% 73% 72% 69% 68% 62% 67% 69% 71% 82% 70% 70% 67% 63% 69% 69% 67% 71% 65% 74% 73% 67% 75% 66% 70% 68% 69% 74% 70% 65% 68% 76% 71% 71% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.841670
GSM549102patient 115, normal, homogenized [OPG study]6.8312570
GSM549104patient 119, normal, homogenized [OPG study]6.7978169
GSM549108patient 138, normal, homogenized [OPG study]7.1031173
GSM549119patient 077, normal, homogenized [OPG study]7.0390172
GSM549133patient 032, cancer, homogenized [OPG study]6.5669166
GSM549139patient 042, cancer, homogenized [OPG study]6.6470667
GSM549099patient 107, normal, homogenized [OPG study]6.9677772
GSM549109patient 139, normal, homogenized [OPG study]6.6953768
GSM549110patient 046, normal, homogenized [OPG study]7.1003173
GSM549114patient 063, normal, homogenized [OPG study]6.7832969
GSM549122patient 082, normal, homogenized [OPG study]7.1472673
GSM549134patient 033, cancer, homogenized [OPG study]7.0122572
GSM549136patient 036, cancer, homogenized [OPG study]6.8367969
GSM549140patient 044, cancer, homogenized [OPG study]6.7324268
GSM549111patient 047, normal, homogenized [OPG study]6.2378962
GSM549113patient 057, normal, homogenized [OPG study]6.6206567
GSM549132patient 031, cancer, homogenized [OPG study]6.7758969
GSM549137patient 038, cancer, homogenized [OPG study]6.9676971
GSM549142patient 047, cancer, homogenized [OPG study]7.8087282
GSM549100patient 110, normal, homogenized [OPG study]6.8561770
GSM549107patient 135, normal, homogenized [OPG study]6.9030570
GSM549115patient 068, normal, homogenized [OPG study]6.6337267
GSM549116patient 072, normal, homogenized [OPG study]6.344163
GSM549120patient 078, normal, homogenized [OPG study]6.7829369
GSM549131patient 030, cancer, homogenized [OPG study]6.7904969
GSM549118patient 074, normal, homogenized [OPG study]6.6665667
GSM549129patient 027, cancer, homogenized [OPG study]7.0401471
GSM549123patient 088, normal, homogenized [OPG study]6.4894365
GSM549124patient 006, cancer, homogenized [OPG study]7.214374
GSM549126patient 015, cancer, homogenized [OPG study]7.1223273
GSM549128patient 025, cancer, homogenized [OPG study]6.6865767
GSM549103patient 117, normal, homogenized [OPG study]7.1914375
GSM549117patient 073, normal, homogenized [OPG study]6.5175866
GSM549138patient 041, cancer, homogenized [OPG study]6.9186370
GSM549141patient 045, cancer, homogenized [OPG study]6.7518768
GSM549130patient 028, cancer, homogenized [OPG study]6.8021269
GSM549101patient 111, normal, homogenized [OPG study]7.2610574
GSM549105patient 128, normal, homogenized [OPG study]6.9008570
GSM549106patient 134, normal, homogenized [OPG study]6.517965
GSM549112patient 048, normal, homogenized [OPG study]6.6769368
GSM549125patient 011, cancer, homogenized [OPG study]7.3599376
GSM549127patient 024, cancer, homogenized [OPG study]7.0168371
GSM549135patient 035, cancer, homogenized [OPG study]7.0143971